Biocon Ltd share price was down by -2.77% from the previous closing price of ₹359.30. Who are peers of Biocon Ltd? The peers of Biocon Ltd are Sun Pharmaceuticals Industries Ltd, Divis ...

The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

AM(IST)on Wednesday in a weak market. Sun Pharmaceutical Industries Ltd.(up 0.21 per cent) were among the top gainers. J B Chemicals & Pharmaceuticals Ltd.(down 5.05 per cent), Natco Pharma Ltd.(down ...

Defence Minister Rajnath Singh projected Bengaluru as the epicentre of India’s technological future, asserting that the city ...

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

Natural Biocon Standalone June 2024 Net Sales at Rs 0.99 crore, up 263.75% Y-o-Y Aug 19 2024 10:49 AM Natural Biocon Standalone March 2024 Net Sales at Rs 11.37 crore, up 1214.85% Y-o-Y Jun 11 ...

The Nifty Pharma index closed on a negative note on Tuesday. Shares of Divi's Laboratories Ltd.(up 0.14 per cent) ended the ...

At close: 3:29:59 PM GMT+5:30 ...

Read more. Jan 30, 2025 22:35 Biocon to Raise Rs 570 Cr via Commercial Papers Biocon Ltd has approved raising Rs 570 crore through issuance of commercial papers on private placement basis. The company ...

Biocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company ...